[1]
Buckstein, R. 2024. Therapy for Myelodysplastic Syndromes Beyond the Front Line in 2024 in Canada. Canadian Hematology Today. 3, 2 (Jun. 2024), 22–29. DOI:https://doi.org/10.58931/cht.2024.3252.